Orris

Is there any protocol as to when to give colloids or albumin in onco surgeon al case

Reading File
Finding Sources
Finding Sources
Searching PubMed

albumin AND perioperative

Searching the Web

perioperative intravenous fluid therapy colloids albumin guidelines crystalloid oncology surgery

Reading File
Reading File
Reading File
Reading Article

PMID: 40059605

Reading Web Page

https://www.nice.org.uk/guidance/cg174

For major oncologic abdominal surgery, there is no universal rule to give albumin simply because the patient has cancer, a low serum albumin, or is having a long operation. The usual protocol is goal-directed fluid therapy (GDFT), with balanced crystalloid as first-line fluid.

Practical intraoperative approach

SituationPreferred action
Routine maintenance / minor deficitsBalanced crystalloid at a conservative rate, adjusted to losses and ERAS pathway
Fluid-responsive hypotension or low stroke volumeGive a small crystalloid challenge first, then reassess stroke volume, PPV/SVV, echo, MAP, lactate, capillary refill, and surgical losses
Ongoing major blood lossBlood-component resuscitation and haemostatic management. Do not use albumin as a substitute for blood
Repeated need for volume despite several crystalloid boluses, especially if edema risk is risingConsider 5% albumin as an alternative volume expander, with reassessment after each bolus
Hypoalbuminemia aloneDo not give albumin solely to correct the laboratory number
Vasodilatory shock not responding to adequate fluid and source controlStart/titrate vasopressor as appropriate. Avoid continuing blind fluid loading
Liver resection / major peritoneal or cytoreductive surgeryIndividualise. Low-CVP periods may be used during transection to reduce bleeding; after that, restore perfusion with GDFT. Albumin may be selectively used when intravascular refilling is needed but excess crystalloid is undesirable
Massive ascites drainage or advanced cirrhosisFollow the liver/ascites-specific albumin protocol, which is a separate indication from ordinary surgical fluid replacement

When albumin is reasonable

Consider albumin only when all are true:
  1. There is evidence of intravascular volume responsiveness, not merely low urine output or low serum albumin.
  2. The patient has already received a reasonable crystalloid trial, or further crystalloid would likely worsen bowel, pulmonary, or tissue edema.
  3. There is ongoing third spacing or substantial operative loss, but bleeding is controlled and blood products are used if indicated.
  4. The response is reassessed after each small bolus using dynamic haemodynamic indices or echocardiography, rather than giving a pre-set volume.
A common local practice is a small 5% albumin bolus, for example 200-250 mL, then reassess. The exact volume and trigger should follow your institution’s anaesthesia/ICU policy and the patient’s cardiac and renal function.

What not to do

  • Do not use albumin routinely in every oncosurgery patient.
  • Do not treat serum albumin alone. It is mainly a marker of inflammation, nutrition, and illness severity perioperatively.
  • Do not use synthetic starch colloids such as HES routinely, particularly with sepsis, renal dysfunction, coagulopathy, or major bleeding risk.
  • Do not chase urine output with repeated fluid boluses without assessing perfusion and fluid responsiveness.
  • Avoid both extremes: excessive fluid causes tissue and bowel edema, impaired healing, and pulmonary complications, while overly restrictive fluid regimens can increase AKI risk.
Textbook guidance supports crystalloids as initial therapy and notes that colloids can restore severe intravascular deficits with less volume, but crystalloid is effective when appropriately dosed. Large crystalloid volumes can contribute to tissue edema. Morgan and Mikhail's Clinical Anesthesiology, 7e, pp. 2251-2252. Goal-directed therapy is generally preferable to indiscriminate liberal fluid replacement in major surgery. Barash, Cullen, and Stoelting's Clinical Anesthesia, 9e, pp. 591-592.
The recent evidence does not show a clear routine outcome benefit from perioperative albumin in major non-cardiac surgery: a 2025 systematic review included only four trials with 426 patients and found no significant reduction in moderate postoperative complications, blood loss, wound infection, or AKI (review abstract). Thus, albumin should be a selective rescue/volume-sparing tool, not standard replacement fluid.
A useful one-line protocol:
Balanced crystalloid first, dynamic-monitor-guided boluses, blood products for haemorrhage, vasopressors for vasoplegia, and 5% albumin only for persistent fluid-responsive intravascular depletion when further crystalloid is undesirable.

Can albumin be given in case of hypotension in oncosurgeries

Reading File
Finding Sources
Finding Sources
Searching PubMed

albumin AND perioperative hypotension

Searching the Web

intraoperative hypotension fluid responsiveness albumin perioperative guidelines

Yes, but only if the hypotension is due to intravascular volume depletion and the patient is fluid responsive. Albumin is not a general treatment for every episode of intraoperative hypotension in oncosurgery.
First assess the cause of hypotension:
  • Bleeding: control source, check Hb/coagulation, give PRBCs and appropriate blood components as indicated. Albumin does not replace oxygen-carrying capacity or clotting factors.
  • Anaesthetic or epidural-related vasodilation: use vasopressor, such as phenylephrine/norepinephrine depending on physiology, rather than repeated fluids.
  • Fluid-responsive hypovolaemia from fasting, bowel prep, third spacing, ascites loss, or surgical losses: give a balanced crystalloid bolus first and reassess.
  • Cardiac dysfunction, arrhythmia, obstruction, anaphylaxis, sepsis: treat the underlying cause. Albumin may be harmful or simply ineffective if the patient is not preload responsive.

Where 5% albumin fits

It can be a reasonable second-line volume expander during prolonged major abdominal/pelvic cancer surgery when:
  • a dynamic test suggests fluid responsiveness, such as increased stroke volume after a test bolus, appropriate PPV/SVV context, or echo findings;
  • repeated crystalloid boluses have not maintained perfusion, or further crystalloid is likely to cause substantial bowel/pulmonary/interstitial edema;
  • there is ongoing non-haemorrhagic intravascular loss or major third spacing; and
  • you reassess immediately after a small bolus, rather than giving it automatically.
A common practice is to give 5% albumin in small boluses, often 200-250 mL, with reassessment of MAP, stroke volume/cardiac output, lactate trend, capillary refill, urine output, and evidence of congestion. Follow your institution's anesthesia protocol for dose limits and monitoring.

Avoid using albumin if

  • hypotension is due to active significant blood loss without blood-product replacement;
  • the patient is not fluid responsive or already fluid overloaded;
  • hypotension is predominantly vasoplegic;
  • the only reason is a low serum albumin value;
  • there is traumatic brain injury, where albumin-based resuscitation has been associated with harm.
In short:
Hypotension + fluid responsiveness + need to limit crystalloid burden: albumin can be considered.
Hypotension from vasodilation: use a vasopressor.
Hypotension from haemorrhage: use blood and haemostatic resuscitation.
Crystalloids are generally effective first-line volume replacement, while colloids restore intravascular volume with less infused volume; severe intravascular deficits may be corrected faster with colloid, but the indication must be physiological rather than based on the surgical diagnosis. Morgan and Mikhail's Clinical Anesthesiology, 7e, pp. 2251-2252. Recent non-cardiac-surgery evidence does not establish a routine outcome benefit for albumin, supporting selective rather than routine use (2025 systematic review).
This is a shared conversation. Sign in to Orris to start your own chat.